EMEA-001398-PIP02-13
Key facts
| Active substance |
|
| Therapeutic area |
Diagnostic
|
| Decision number |
P/0299/2013
|
| PIP number |
EMEA-001398-PIP02-13
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
| Condition(s) / indication(s) |
Diagnosis of beta-lactam allergy
|
| Route(s) of administration |
|
| Contact for public enquiries |
Diater Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A.
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-001398-PIP02-13
|
| Compliance opinion date |
12/09/2014
|
| Compliance outcome |
positive
|